ROHIT SRIVASTAVA to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications ROHIT SRIVASTAVA has written about Histone Deacetylase Inhibitors.
Connection Strength
0.044
-
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 Apr; 80(4):610-621.
Score: 0.044
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.